This company listing is no longer active
NXTMS Stock Overview
A medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Nexstim Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €40.40 |
| 52 Week High | €56.90 |
| 52 Week Low | €36.00 |
| Beta | 1.67 |
| 1 Month Change | 1.64% |
| 3 Month Change | -10.32% |
| 1 Year Change | -26.14% |
| 3 Year Change | -46.13% |
| 5 Year Change | -99.44% |
| Change since IPO | -99.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| NXTMS | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 1.0% | 5.6% | 1.1% |
| 1Y | -26.1% | -0.2% | 13.3% |
Return vs Industry: NXTMS exceeded the Swedish Medical Equipment industry which returned -31.6% over the past year.
Return vs Market: NXTMS underperformed the Swedish Market which returned -9.3% over the past year.
Price Volatility
| NXTMS volatility | |
|---|---|
| NXTMS Average Weekly Movement | 6.1% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.7% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: NXTMS has not had significant price volatility in the past 3 months.
Volatility Over Time: NXTMS's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 39 | Mikko Karvinen | www.nexstim.com |
Nexstim Plc, a medical technology company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company’s proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers Navigated Brain Therapy system, a navigated brain therapy system for the treatment of major depression and chronic neuropathic pain; and Navigated Brain Stimulation (NBS) system, a navigated brain stimulation system for pre-surgical mapping of the speech and motor cortices of the brain.
Nexstim Plc Fundamentals Summary
| NXTMS fundamental statistics | |
|---|---|
| Market cap | SEK 288.81m |
| Earnings (TTM) | SEK 14.79m |
| Revenue (TTM) | SEK 121.81m |
19.5x
P/E Ratio2.4x
P/S RatioIs NXTMS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NXTMS income statement (TTM) | |
|---|---|
| Revenue | €10.76m |
| Cost of Revenue | €1.24m |
| Gross Profit | €9.52m |
| Other Expenses | €8.21m |
| Earnings | €1.31m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
Aug 18, 2023
| Earnings per share (EPS) | 0.19 |
| Gross Margin | 88.47% |
| Net Profit Margin | 12.14% |
| Debt/Equity Ratio | 85.8% |
How did NXTMS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/04/18 17:52 |
| End of Day Share Price | 2023/04/14 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nexstim Plc is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Petri Kajaani | Inderes Oy |
| Antti Siltanen | Inderes Oy |
| Yilmaz Mahshid | Pareto Securities |